#83, Designing Optimal Drug Molecules from Scratch with Dave Longo from Ordaōs
Listen now
Description
Ordaōs, a human-enabled machine-driven drug design company leveraging GenAI and AI/ML to design and build mini proteins as therapeutics for biomedical research and drug discovery.
More Episodes
Iktos is an innovative company specializing in the development of artificial intelligence solutions applied to chemical research and new drug design, enabling major productivity gains in upstream pharmaceutical R&D.
Published 05/07/24
DeepLife uses machine learning to curate and annotate single-cell RNA-seq datasets, enabling downstream bioinformatics analysis and target identification.
Published 04/30/24
Published 04/30/24